To Enhance the Anti-Cancer Ability of Cytokine-Induced Killer (Cik) Cells from Patients with Hepatocellular Carcinoma by Interleukins 12, 15 and 18

Yang, Chan-Keng (PI)
Lin, Chun-Yen (CoPI)
Lin, Yung-Chang (CoPI)

School of Medicine

Project: National Science and Technology Council › National Science and Technology Council Academic Grants

Abstract

肝癌在亞洲的發生率高，然而肝癌的複發率也高且晚期病人的預後很差。癌症免疫治療近年在臨床的發展快速。過繼性T細胞治療作用於肝癌的病人是一種有潛力的輔助性抗癌治療。本研究目的是利用不同細胞因子刺激或免療藥物的組合方式以增強「細胞因子誘導的殺手細胞」的毒殺能力。未來有機會作為肝癌的細胞治療。

Project IDs

Project ID:PC11307-2644
External Project ID:NSTC113-2628-B182-004-MY2

Status	Active
Effective start/end date	01/08/24 → 31/07/25

Keywords

cytokine-induced killer cells
interleukin
anticancer activity
hepatocellular carcinoma
cell therapy

Access Project

https://www.grb.gov.tw/search/planDetail?id=16594930